Nuclear Medicine and Radiopharmaceuticals Market Report

Global and Europe Nuclear Medicine and Radiopharmaceuticals Market Professional Survey Report 2019

  • POSTDATE：Jan 18, 2020
  • PAGES：217
  • REPORT CODE：GMM440252
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Nuclear Medicine and Radiopharmaceuticals market was valued at XX.0 million US$ in 2018, with the CAGR of 3.3%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Nuclear Medicine and Radiopharmaceuticals market. Describe product range of Nuclear Medicine and Radiopharmaceuticals, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Nuclear Medicine and Radiopharmaceuticals market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Nuclear Medicine and Radiopharmaceuticals market.

     

    By Player

    • IBA Group

    • Dongcheng

    • Nordion

    • GE Healthcare

    • Mallinckrodt

    • Bayer

    • Bracco Imaging

    • SIEMENS

    • Eli Lilly

    • Navidea

    • Jubilant Pharma

    • Triad Isotopes

    • Advanced Accelerator Applications

    • Lantheus

    • China Isotope & Radiation

    By Type

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User

    • Oncology

    • Cardiology

    • Other

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine and Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

      • 1.3.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine and Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine and Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Radioisotopes

      • 3.4.2 Market Size and Growth Rate of Therapeutic Radioisotopes

    4 Segmentation of Nuclear Medicine and Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine and Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals for Oncology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals for Cardiology

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals for Other

    5 Market Analysis by Major Regions

    • 5.1 Global Nuclear Medicine and Radiopharmaceuticals Production Analysis by Top Regions

    • 5.2 Global Nuclear Medicine and Radiopharmaceuticals Consumption Analysis by Top Regions

    • 5.3 Global Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    6 Product Circulation of Nuclear Medicine and Radiopharmaceuticals Market among Top Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 7.1 North America Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Top Countries

      • 7.1.1 United States Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 7.1.2 Canada Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 7.1.3 Mexico Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

    8. Europe Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 8.1 Europe Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Europe Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 8.3 Europe Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Top Countries

      • 8.3.1 Germany Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.2 UK Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.3 France Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.4 Italy Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.5 Spain Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.6 Belgium Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.7 Poland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.8 Russia Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.9 Turkey Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.10 Netherlands Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.11 Portugal Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.12 Denmark Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.13 Finland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.14 Iceland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.15 Norway Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.16 Sweden Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 9.1 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Top Countries

      • 9.1.1 China Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 9.1.2 Japan Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 9.1.4 India Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 9.1.5 ASEAN Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 9.1.6 South Korea Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

    10 LAMEA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 10.1 LAMEA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 10.1.2 Brazil Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 10.1.3 North Africa Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 10.1.4 South Africa Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

      • 10.1.5 Argentina Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 IBA Group

      • 11.1.1 IBA Group Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Dongcheng

      • 11.2.1 Dongcheng Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Nordion

      • 11.3.1 Nordion Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 GE Healthcare

      • 11.4.1 GE Healthcare Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Mallinckrodt

      • 11.5.1 Mallinckrodt Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Bayer

      • 11.6.1 Bayer Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Bracco Imaging

      • 11.7.1 Bracco Imaging Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 SIEMENS

      • 11.8.1 SIEMENS Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Eli Lilly

      • 11.9.1 Eli Lilly Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Navidea

      • 11.10.1 Navidea Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Jubilant Pharma

      • 11.11.1 Jubilant Pharma Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Triad Isotopes

      • 11.12.1 Triad Isotopes Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Advanced Accelerator Applications

      • 11.13.1 Advanced Accelerator Applications Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Lantheus

      • 11.14.1 Lantheus Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 China Isotope & Radiation

      • 11.15.1 China Isotope & Radiation Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 108 Figures and 154 Tables)

    • Figure Product Picture

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Global Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Other from 2014 to 2026

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure United States Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure China Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine and Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine and Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine and Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine and Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Other

    • Table Global Nuclear Medicine and Radiopharmaceuticals Production by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceuticals Production Share by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceuticals Consumption by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Regions

    • Table North America Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table LAMEA Nuclear Medicine and Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine and Radiopharmaceuticals Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Nuclear Medicine and Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table North America Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries in 2014

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure North America Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries in 2026

    • Figure United States Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure China Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine and Radiopharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine and Radiopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Nuclear Medicine and Radiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US